VCAM1 and cancer: Anti-VCAM-1 antibodies could also be used for diagnostic purposes, to identify VCAM-1 expressing cancer or atherosclerotic plaques, etc. Cross-reactivity of these antibodies with other Ig-like domain containing proteins could be a potential issue that may require further in silico and in vitro testing before moving into pre-clinical models.